OpenLegislation

Division 1.2.10

United Kingdom

Original text. Later amendments are not shown.

Aminoglycosides

Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget issues
‘DihydrostreptomycinDihydrostreptomycinAll ruminants500 μg/kgMuscle
500 μg/kgFat
500 μg/kgLiver
1 000 μg/kgKidney
200 μg/kgMilk
Porcine500 μg/kgMuscle
500 μg/kgSkin + fat
500 μg/kgLiver
1 000 μg/kgKidney
Rabbits500 μg/kgMuscle
500 μg/kgFat
500 μg/kgLiver
1 000 μg/kgKidney
StreptomycinStreptomycinAll ruminants500 μg/kgMuscle
500 μg/kgFat
500 μg/kgLiver
1 000 μg/kgKidney
200 μg/kgMilk
Porcine500 μg/kgMuscle
500 μg/kgSkin + fat
500 μg/kgLiver
1 000 μg/kgKidney
Rabbits500 μg/kgMuscle
500 μg/kgFat
500 μg/kgLiver
1 000 μg/kgKidney’